![Sunil Karnawat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Karnawat
Corporate Officer/Principal chez
REZOLUTE, INC.
Fortune : 163 152 $ au 31/05/2026
Profil
Sunil Karnawat currently works at Rezolute, Inc., as Chief Commercial Officer from 2025.
Dr. Karnawat also formerly worked at Cytokinetics, Inc., as Vice President and Ultragenyx Pharmaceutical, Inc., as Vice President.
Dr. Karnawat received his graduate degree and doctorate degree from North Dakota State University, undergraduate degree from College of Engineering, Pune, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REZOLUTE, INC. 0,06% | 15/12/2025 | 49 440 ( 0,06% ) | 163 152 $ | 31/05/2026 |
Postes actifs de Sunil Karnawat
| Sociétés | Poste | Début |
|---|---|---|
| REZOLUTE, INC. | Corporate Officer/Principal | 18/08/2025 |
Anciens postes connus de Sunil Karnawat
| Sociétés | Poste | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Formation de Sunil Karnawat
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
North Dakota State University
 North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Engineering, Pune
 College of Engineering, Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
